FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1520408486> ?p ?o ?g. }

• W1520408486 endingPage "48336" @default.
• W1520408486 startingPage "48332" @default.
• W1520408486 abstract "Mice lacking expression of the p66 isoform of the ShcA adaptor protein (p66ShcA) are less susceptible to oxidative stress and have an extended life span. Specifically, phosphorylation of p66ShcA at serine 36 is critical for the cell death response elicited by oxidative damage. We sought to identify the kinase(s) responsible for this phosphorylation. Utilizing the SH-SY5Y human neuroblastoma cell model, it is demonstrated that p66ShcA is phosphorylated on serine/threonine residues in response to UV irradiation. Both c-Jun N-terminal kinases (JNKs) and p38 mitogen-activated protein kinases are activated by UV irradiation, and we show that both are capable of phosphorylating serine 36 of p66ShcA in vitro. However, treatment of cells with a multiple lineage kinase inhibitor, CEP-1347, that blocks UV-induced JNK activation, but not p38, phosphatidylinositol 3-kinase, or MEK1 inhibitors, prevented p66ShcAphosphorylation in SH-SY5Y cells. Consistent with this finding, transfected activated JNK1, but not the kinase-dead JNK1, leads to phosphorylation of serine 36 of p66ShcA in Chinese hamster ovary cells. In conclusion, JNKs are the kinases that phosphorylate serine 36 of p66ShcA in response to UV irradiation in SH-SY5Y cells, and blocking p66ShcA phosphorylation by intervening in the JNK pathway may prevent cellular damage due to light-induced oxidative stress. Mice lacking expression of the p66 isoform of the ShcA adaptor protein (p66ShcA) are less susceptible to oxidative stress and have an extended life span. Specifically, phosphorylation of p66ShcA at serine 36 is critical for the cell death response elicited by oxidative damage. We sought to identify the kinase(s) responsible for this phosphorylation. Utilizing the SH-SY5Y human neuroblastoma cell model, it is demonstrated that p66ShcA is phosphorylated on serine/threonine residues in response to UV irradiation. Both c-Jun N-terminal kinases (JNKs) and p38 mitogen-activated protein kinases are activated by UV irradiation, and we show that both are capable of phosphorylating serine 36 of p66ShcA in vitro. However, treatment of cells with a multiple lineage kinase inhibitor, CEP-1347, that blocks UV-induced JNK activation, but not p38, phosphatidylinositol 3-kinase, or MEK1 inhibitors, prevented p66ShcAphosphorylation in SH-SY5Y cells. Consistent with this finding, transfected activated JNK1, but not the kinase-dead JNK1, leads to phosphorylation of serine 36 of p66ShcA in Chinese hamster ovary cells. In conclusion, JNKs are the kinases that phosphorylate serine 36 of p66ShcA in response to UV irradiation in SH-SY5Y cells, and blocking p66ShcA phosphorylation by intervening in the JNK pathway may prevent cellular damage due to light-induced oxidative stress. mitogen-activated protein kinase c-Jun N-terminal kinase extracellular signal-regulated kinase mitogen-activated protein kinase kinase kinase mitogen activated protein kinase kinase mixed lineage kinase collagen-homologous region 1/2 Chinese hamster ovary calmodulin-binding protein myelin basic protein wild type insulin-like growth factor-1 The accumulation of oxidative cellular damage has been noted in a number of aging and neurodegenerative diseases, such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (1Smith M.A. Richey P.L. Sayre L.M. Beckman J.S. Perry G. J. Neurosci. 1997; 17: 2563-2657Google Scholar, 2Jellinger K.A. J. Neural Transm. 2000; 107: 1-29Crossref PubMed Scopus (198) Google Scholar, 3Robberecht W. J. Neurol. 2000; 247: 1-6Crossref Google Scholar, 4Albers D.S. Beal M.F. J. Neural Transm. 2000; 59: 133-154Google Scholar). The molecular mechanisms leading to oxidative cell death have not been not fully elucidated; however, recent studies suggest that phosphorylation cascades may be involved in events triggered by free radical overproduction. For example, members of the mitogen-activated protein kinase (MAPK)1 family, including p38 and JNKs, are activated upon exposure of cells to DNA-damaging agents, hydrogen peroxide, UV irradiation, and hypoxia (5Karin M. Ann. N. Y. Acad. Sci. 1998; 851: 139-146Crossref PubMed Scopus (289) Google Scholar, 6Davis R.J. Hughes H. Cell. 2000; 103: 239-252Abstract Full Text Full Text PDF PubMed Scopus (3609) Google Scholar, 7Miekle K. Herdegen T. Prog. Neurobiol. 2000; 61: 45-60Crossref PubMed Scopus (434) Google Scholar, 8Harper S.J. LoGrasso P. Cell. Signal. 2001; 13: 229-310Crossref Scopus (278) Google Scholar, 9Salh B.S. Martens J. Hundal R.S. Yoganathan N. Charest D. Mui A. Gomez-Munot A. Mol. Cell. Biol. Res. Commun. 2000; 4: 158-165Crossref PubMed Scopus (26) Google Scholar). However, it is not clear what events downstream of kinase activation contribute to the ultimate damage induced by oxidative stress. In this regard, it is of interest that phosphorylation of the p66ShcA adaptor protein has been shown to play an important role in signaling events leading to cell death in response to oxidative damage (10Migliaccio E. Giorgio M. Mele S. Pelicci G. Reboldi P. Pandolfi P.P. Lanfrancone L. Pelicci P.G. Nature. 1999; 402: 309-313Crossref PubMed Scopus (1463) Google Scholar). The mammalian ShcA adaptor protein has three isoforms: p46, p52, and p66 (11Luzi L. Confalonieri S. Di Fiore P.P. Pelicci P.G. Curr. Opin. Genet. Dev. 2000; 10: 668-674Crossref PubMed Scopus (188) Google Scholar). All Shc isoforms contain a common structure with a C-terminal SH2 (Src homology 2) domain, a proline- and glycine-rich region, collagen-homologous region 1 (CH1), and an N-terminal PTB (phosphotyrosine binding) domain (12Pelicci G. Lanfrancone L. Grignani F. Forni G. Cavallo F. Forni G. Nicoletti I. Grinani F. Pawson T. Pelicci P.G. Cell. 1992; 70: 93-104Abstract Full Text PDF PubMed Scopus (1135) Google Scholar). In addition, there is a unique collagen homologous region 2 (CH2) domain at the N terminus of the p66ShcA isoform. It is well established that the Shc proteins are phosphorylated at tyrosine residues in response to stimulation by a variety of growth factors and cytokines (12Pelicci G. Lanfrancone L. Grignani F. Forni G. Cavallo F. Forni G. Nicoletti I. Grinani F. Pawson T. Pelicci P.G. Cell. 1992; 70: 93-104Abstract Full Text PDF PubMed Scopus (1135) Google Scholar, 13Rozakis-Adcock M. McGlade J. Mbamalu G. Pelicci G. Daly R. Li W. Batzer A. Thomas S. Brugge J. Pelicci P.G. Schlessinger J. Pawson T. Nature. 1992; 360: 689-692Crossref PubMed Scopus (826) Google Scholar, 14Pronk G.J. McGlade J. Pelicci G. Pawson T. Bos J.L. J. Biol. Chem. 1993; 268: 5748-5753Abstract Full Text PDF PubMed Google Scholar, 15Ruff-Jamison S. McGlade J. Pawson T. Chen K. Cohen S. J. Biol. Chem. 1993; 268: 7610-7612Abstract Full Text PDF PubMed Google Scholar, 16Cutler R.L. Liu L. Damen J.E. Krystal G. J. Biol. Chem. 1993; 268: 21463-21465Abstract Full Text PDF PubMed Google Scholar). The p46 and p52 isoforms transmit signals from receptor tyrosine kinases to the Ras/MAPK pathway by forming a stable complex involving Grb2 and a Ras exchange factor, SOS (Son of Sevenless) (12Pelicci G. Lanfrancone L. Grignani F. Forni G. Cavallo F. Forni G. Nicoletti I. Grinani F. Pawson T. Pelicci P.G. Cell. 1992; 70: 93-104Abstract Full Text PDF PubMed Scopus (1135) Google Scholar, 17Skolnik E.Y. Batzer A. Li N. Lee C.H. Lowenstein E. Mohammadi M. Margolis B. Schlessinger J. Science. 1993; 260: 1953-1955Crossref PubMed Scopus (502) Google Scholar, 18Egan S.E. Giddings B.W. Brooks M.W. Buday L. Sizeland A.M. Weinberg R.A. Nature. 1993; 363: 45-51Crossref PubMed Scopus (1008) Google Scholar, 19Aronheim A. Engelberg D. Li N. Al-Alawi N. Schlessinger J. Karin M. Cell. 1994; 78: 949-961Abstract Full Text PDF PubMed Scopus (422) Google Scholar, 20Kavanaugh W.M. Williams L.T. Science. 1994; 266: 1862-1865Crossref PubMed Scopus (450) Google Scholar, 21Ohmichi M. Matuoka K. Takenawa T. Saltiel A.R. J. Biol. Chem. 1994; 269: 1143-1148Abstract Full Text PDF PubMed Google Scholar). However, p66ShcA appears functionally different from the p46 and p52 isoforms. Unlike the other isoforms, p66 does not transform mouse fibroblasts, nor does it induce MAPK activation, although p66ShcA is transiently phosphorylated at tyrosine residues in response to growth factor stimulation (22Bonfini L. Migliaccio E. Pelicci G. Lanfrancone L. Pelicci P.G. Trends Biochem. Sci. 1996; 21: 257-261Abstract Full Text PDF PubMed Scopus (234) Google Scholar, 23Migliaccio E. Mele S. Salcini A.E. Pelicci G. Lai K.M. Superti-Furga G. Pawson T. Di Fiore P.P. Lanfrancone L. Pelicci P.G. EMBO J. 1997; 16: 706-716Crossref PubMed Scopus (362) Google Scholar). The p66 protein is phosphorylated at serine/threonine residues in response to insulin, Taxol, UV, or H2O2treatment (10Migliaccio E. Giorgio M. Mele S. Pelicci G. Reboldi P. Pandolfi P.P. Lanfrancone L. Pelicci P.G. Nature. 1999; 402: 309-313Crossref PubMed Scopus (1463) Google Scholar, 24Kao A.W. Waters S.B. Okada S. Pessin J.E. Endocrinology. 1997; 138: 747-7480Crossref Scopus (51) Google Scholar, 25Yang C.H. Horwitz S.B. Cancer Res. 2000; 60: 5171-5178PubMed Google Scholar). It has recently been demonstrated that, in response to UV and H2O2 treatment, p66ShcA is phosphorylated mainly at serine 36 in the N-terminal CH2 domain (10Migliaccio E. Giorgio M. Mele S. Pelicci G. Reboldi P. Pandolfi P.P. Lanfrancone L. Pelicci P.G. Nature. 1999; 402: 309-313Crossref PubMed Scopus (1463) Google Scholar). p66ShcA-null mouse fibroblast cells have enhanced cellular resistance to oxidative damage (10Migliaccio E. Giorgio M. Mele S. Pelicci G. Reboldi P. Pandolfi P.P. Lanfrancone L. Pelicci P.G. Nature. 1999; 402: 309-313Crossref PubMed Scopus (1463) Google Scholar). Wild type p66ShcA, but not a phosphorylation-defective mutant, can restore the normal stress response in the p66ShcA-null mouse fibroblast cells. Moreover, mice lacking expression of p66ShcA are less susceptible to chemical induced oxidative damage by paraquat and have an extended life span (10Migliaccio E. Giorgio M. Mele S. Pelicci G. Reboldi P. Pandolfi P.P. Lanfrancone L. Pelicci P.G. Nature. 1999; 402: 309-313Crossref PubMed Scopus (1463) Google Scholar). Therefore, p66ShcA, particularly its phosphorylation at serine 36, appears to be important for the cell death response upon oxidative stress, and the prevention of this phosphorylation may have therapeutic impact on diseases that are associated with oxidative damage. We sought to identify the kinase(s) responsible for phosphorylating serine 36 of p66ShcA. We report here that JNK1, JNK2, and JNK3 phosphorylate p66ShcA in vitro and further demonstrate that blocking JNK activation prevents p66ShcAphosphorylation in UV-irradiated SH-SY5Y human neuroblastoma cells. The kinase inhibitors SB203580, LY294002, and PD98059 were purchased from BIOMOL Research Laboratories (Plymouth Meeting, PA). CEP-1347, also known as KT7515, is a semi-synthetic derivative of K-252a and was provided by Kyowa-Hakko (Tokyo) (26Kaneko M. Saito Y. Saito H. Matsumoto T. Matsuda Y. Vaught J.L. Dionne C.A. Angeles T.S. Glicksman M.A. Neff N.T. Rotella D.P. Kauer J.C. Mallamo J.P. Hudkins R.L. Murakata C. J. Med. Chem. 1997; 40: 1863-1869Crossref PubMed Scopus (123) Google Scholar). All stocks of inhibitors were dissolved in dimethyl sulfoxide (Me2SO) and stored at −20 °C in amber glass vials. Further dilutions were made in appropriate solutions containing 0.05% bovine serum albumin (Fraction V, Protease-free). Pefabloc and bovine serum albumin were purchased from Roche Molecular Biochemicals. Dulbecco’s modified Eagle’s medium, Neural Basal media, and B-27 serum-free supplement were purchased from Life Technologies, Inc. Aprotinin and protease inhibitor mixture were purchased from Sigma. Recombinant mixed lineage kinases (MLKs) and JNK3α1 were made as described elsewhere (27Maroney A.C. Finn J.P. Connors T.J. Durkin J.T. Angeles T. Gessner G. Xu Z. Meyer S.L. Savage M.J. Greene L.A. Scott R.W. Vaught J.L. J. Biol. Chem. 2001; 276: 25302-25308Abstract Full Text Full Text PDF PubMed Scopus (192) Google Scholar, 28Zheng C.F. Simcox T. Xu L. Vaillancourt P. Gene. 1997; 186: 55-60Crossref PubMed Scopus (51) Google Scholar). Recombinant active MEKK1, MKK4, MKK7, JNK1α1, JNK2α2, p38, ERK1, and immunoprecipitating p66ShcA antibody were purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). Western blotting p66ShcA antibody was purchased from Transduction Laboratories (Lexington, KY). The Grb2 antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Phospho-JNK and JNK antibody were purchased from Cell Signaling Technology (Beverly, MA). Myc antibody was purchased from Babco (Richmond, CA). IGF-1 was purchased from Calbiochem (San Diego, CA). The human neuroblastoma cell line SH-SY5Y, kindly provided by Dr. June Biedler (Memorial Sloan-Kettering Cancer Center, Rye, NY) and the Chinese hamster ovary cells (CHO; ATCC CCL-61) from the American Type Culture Collection (Manassas, VA) were maintained in Dulbecco’s modified Eagle’s medium with 10% fetal bovine serum at 37 °C in 10% CO2. Cells were detached for passage by adding 0.25% trypsin. For all experiments in the presence of compounds the cells were maintained in Neural Basal media supplemented with B27 serum-free nutrient. In experiments utilizing MAPK inhibitors, cells were treated with vehicle (0.2% dimethyl sulfoxide), 15 μm SB203580, 0.5 μm CEP-1347, 10 μm LY294002, or 50 μm PD98059 for 1 h at 37 °C. Cells in a minimal amount of medium were irradiated in a UV Stratalinker (Stratagene, La Jolla, CA) for varying times as indicated. The medium was then restored, and the cells were returned to the incubator for varying amounts of time before further analysis. Cell extracts were prepared by suspending cells in lysis buffer containing 10 mm Tris, 50 mm NaCl, 1% Triton X-100, 2 mm sodium vanadate, 0.2 mm4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF, Roche Molecular Biochemicals), and proteinase inhibitor mixture (Sigma). Immunoblots and immunoprecipitations were performed according to the procedure of Harlow and Lane (29Harlow E. Lane D. Antibodies, a Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York1988Google Scholar). Cell lysates or immunoprecipitates were separated on precast 10% Tris/glycine SDS-PAGE gels (Invitrogen, San Diego, CA), transferred to polyvinylidene difluoride membranes (Millipore, Chicago, IL), and probed with antibodies as indicated in buffer containing 10 mm Tris-HCl (pH 7.2), 150 mm NaCl, 0.1% Triton X-100, and 3% bovine serum albumin. After incubating with alkaline phosphatase-conjugated secondary antibody, blots were developed by the ECF reagent (Amersham Biosciences, Inc.) and analyzed on the STORM PhosphorImager system (Molecular Dynamics, San Francisco, CA). In the instances where the degree of the p66ShcA mobility shift was determined, the distance between the peak volume of the p66ShcA band relative to the reference p52 band was determined for each sample on the PhosphorImager. In the alkaline phosphatase experiment, immunoprecipitated samples were treated with PP2A1 (Upstate Biotechnology, Inc.) as described elsewhere (25Yang C.H. Horwitz S.B. Cancer Res. 2000; 60: 5171-5178PubMed Google Scholar). In brief, immunoprecipitates were incubated with PP2A1 for 30 min at 30 °C. The reaction was stopped by adding sample buffer and boiling. Mouse p66ShcAcDNA was provided by Dr. Jeffrey Pessin (University of Iowa, Iowa City, IA (30Okada S Kao A.W. Ceresa B.P. Blaikie P. Margolis B. Pessin J.E. J. Biol. Chem. 1997; 272: 28042-28049Abstract Full Text Full Text PDF PubMed Scopus (119) Google Scholar)). Serine 36 was mutagenized to alanine using the QuikChange kit (Stratagene). The JNK1 kinase-dead (JNK1KD) plasmid was constructed by substituting an Eco RV-Eco RI fragment of the pcDNA3-HA-JNK1 with a similar fragment that contained alanine 55 instead of lysine. DNAs were transfected into CHO cells by LipofectAMINE Plus reagents as described by the manufacturer (Life Technologies, Inc.). For generating calmodulin-binding protein (CBP)-p66ShcA fusion proteins, either wild type or mutant S36A p66ShcA cDNA was cloned into pCal-n (Stratagene) to generate CBP-p66ShcA fusions. Expression plasmids were transformed into BL21(DE3) Escherichia coli strain (Novagen, Madison, WI) and grown to mid-log phase. Protein expression was induced by 1 mmisopropyl-1-thio-β-d-galactopyranoside at 30 °C for 3 h. Bacterial lysates were purified on a calmodulin affinity column according to the manufacturer’s protocol (Stratagene). In the in vitro kinase assay, different kinases including MEKK1 (0.1 μg), MKK4 (0.2 μg), MKK7α (0.9 μg), JNK1α1 (0.6 μg), JNK2α2 (0.3 μg), JNK3 (0.3 μg), p38 (0.3 μg), ERK1 (0.3 μg), MLK1 (0.04 μg), MLK2 (0.1 μg), and MLK3 (0.1 μg) were incubated with buffer (control), 1 μg of wild type p66ShcA or mutant p66ShcA S36A proteins, and [32P]ATP in kinase buffer (20 mmHepes, pH 7.6, 20 mm MgCl2, 2 mmdithiothreitol, 1 μm ATP, 0.2 mm sodium vanadate, and 25 mm β-glycerol phosphate) at 30 °C for 30 min. In control reactions, 20 μg of myelin basic protein (MBP; Sigma) was used instead of p66ShcA proteins. The reactions were stopped by adding sample buffer and heating at 80 °C for 10 min. The p66ShcA or the MBP-containing samples were loaded on a 7.5 or 12% SDS-PAGE gel, respectively, dried, and analyzed on the STORM PhosphorImager system (Molecular Dynamics). P66ShcA is serine/threonine-phosphorylated in response to growth factors, such as epidermal growth factor and insulin, and to cellular stress induced by UV irradiation, hydrogen peroxide, or Taxol treatment (30Okada S Kao A.W. Ceresa B.P. Blaikie P. Margolis B. Pessin J.E. J. Biol. Chem. 1997; 272: 28042-28049Abstract Full Text Full Text PDF PubMed Scopus (119) Google Scholar,24Kao A.W. Waters S.B. Okada S. Pessin J.E. Endocrinology. 1997; 138: 747-7480Crossref Scopus (51) Google Scholar, 10Migliaccio E. Giorgio M. Mele S. Pelicci G. Reboldi P. Pandolfi P.P. Lanfrancone L. Pelicci P.G. Nature. 1999; 402: 309-313Crossref PubMed Scopus (1463) Google Scholar, 25Yang C.H. Horwitz S.B. Cancer Res. 2000; 60: 5171-5178PubMed Google Scholar). To determine whether p66ShcA was also phosphorylated on serine/threonine residues in response to cellular stress in a neuronal environment, the human neuroblastoma SH-SY5Y cell line was UV-irradiated, and electrophoretic mobility was assessed. A retarded electrophoretic mobility shift of p66ShcA was observed in response to UV irradiation after 3 h of post-treatment incubation (Fig. 1, A and B, lanes 1 and 2). In contrast, the mobilities of the p52 and p46 isoforms were not affected. The decreased mobility of p66ShcA is characteristic of post-translational modifications, such as protein phosphorylation. Indeed, this decreased mobility was abolished by serine/threonine protein phosphatase 2A1 treatment (Fig. 1 A, lanes 4 and 5). These data support the observation that p66ShcA is phosphorylated at serine/threonine residue(s) after UV irradiation in SH-SY5Y cells, similar to previous results obtained in other cell systems (10Migliaccio E. Giorgio M. Mele S. Pelicci G. Reboldi P. Pandolfi P.P. Lanfrancone L. Pelicci P.G. Nature. 1999; 402: 309-313Crossref PubMed Scopus (1463) Google Scholar, 24Kao A.W. Waters S.B. Okada S. Pessin J.E. Endocrinology. 1997; 138: 747-7480Crossref Scopus (51) Google Scholar, 25Yang C.H. Horwitz S.B. Cancer Res. 2000; 60: 5171-5178PubMed Google Scholar, 30Okada S Kao A.W. Ceresa B.P. Blaikie P. Margolis B. Pessin J.E. J. Biol. Chem. 1997; 272: 28042-28049Abstract Full Text Full Text PDF PubMed Scopus (119) Google Scholar). MAPKs, most notably JNKs and p38, have been shown to play an important role in response to oxidative damage in neuronal environments (31McLaughlin B. Pal S. Tran M.P. Parsons A.A. Barone F.C. Erhardt J.A. Aizenman E.J. Neuroscience. 2001; 21: 3303-3311Crossref PubMed Google Scholar, 32Oh-Hashi K. Maruyama W. Isobe K. Free Radic. Biol. Med. 2001; 30: 213-221Crossref PubMed Scopus (115) Google Scholar, 33Luo Y. Umegaki H. Wang X. Abe R. Roth G.S. J. Biol. Chem. 1998; 273: 3756-3764Abstract Full Text Full Text PDF PubMed Scopus (295) Google Scholar, 34Kang C.D. Jang J.H. Kim K.W. Lee H.J Jeong C.S. Kim C.M. Kim S.H. Chung B.S. Neurosci. Lett. 1998; 256: 37-40Crossref PubMed Scopus (61) Google Scholar). To investigate whether the MAPKs were responsible for p66ShcAphosphorylation, several known kinase inhibitors were used to determine whether they could block p66ShcA phosphorylation in response to UV irradiation. SH-SY5Y cells were treated with CEP-1347, an MLK inhibitor, SB203580, a p38 inhibitor, LY294002, a phosphatidylinositol 3-kinase inhibitor, or PD98059, a MEK1 inhibitor, followed by UV irradiation. The SB203580, LY294002, and PD98059 compounds were effective in blocking UV-induced phosphorylation of their respective downstream targets, ATF-2, AKT, and ERK1/2 (data not shown); however, they had no effect on the UV-induced p66ShcA mobility shift (Fig. 1 B). In contrast, at a concentration at which CEP-1347 blocked JNK phosphorylation (data not shown), p66ShcA mobility shift was also inhibited to the same degree as protein phosphatase 2A1 treatment (Fig. 1,A and B). As previously reported, both MLK3 and JNK activation are blocked in the presence of CEP-1347 in SH-SY5Y cells after UV irradiation (27Maroney A.C. Finn J.P. Connors T.J. Durkin J.T. Angeles T. Gessner G. Xu Z. Meyer S.L. Savage M.J. Greene L.A. Scott R.W. Vaught J.L. J. Biol. Chem. 2001; 276: 25302-25308Abstract Full Text Full Text PDF PubMed Scopus (192) Google Scholar). These results suggested that MLKs or kinase(s) regulated by MLKs might be responsible for p66ShcA phosphorylation upon UV irradiation. The major site of serine phosphorylation of p66ShcA after hydrogen peroxide treatment of mouse embryonic fibroblasts is serine 36, and overexpression of a phospho-deficient serine 36 mutant of p66ShcA in p66ShcA-null fibroblasts attenuates hydrogen peroxide induced cell death (10Migliaccio E. Giorgio M. Mele S. Pelicci G. Reboldi P. Pandolfi P.P. Lanfrancone L. Pelicci P.G. Nature. 1999; 402: 309-313Crossref PubMed Scopus (1463) Google Scholar). To determine whether the MLK/JNK pathway affected p66ShcA phosphorylation as suggested by use of the kinase inhibitors in the whole cell studies described above (Fig.1 B) and in an effort to identify the kinase(s) responsible for its phosphorylation, kinases in the MLK/JNK pathway were co-expressed with either wild type (wt p66ShcA) or a serine 36 to alanine (S36A) mutant of p66ShcA and electrophoretic mobility was assessed. The wild type and mutant S36A cDNAs were tagged with a myc epitope and expressed in CHO cells along with MLK3 and JNK1. As described previously (27Maroney A.C. Finn J.P. Connors T.J. Durkin J.T. Angeles T. Gessner G. Xu Z. Meyer S.L. Savage M.J. Greene L.A. Scott R.W. Vaught J.L. J. Biol. Chem. 2001; 276: 25302-25308Abstract Full Text Full Text PDF PubMed Scopus (192) Google Scholar), overexpression of MLK3 led to phosphorylation/activation of JNK (Fig.2 A, lower panel). As shown in Fig. 2 A, in the absence of an upstream activator of JNK1, co-expression of JNK1 with either wt p66ShcA or S36A p66ShcA did not alter the mobility of the Shc proteins. In contrast, co-expression of MLK3, JNK1 and wt p66ShcA, but not S36A p66ShcA protein, induced a decreased electrophoretic mobility of p66ShcA (Fig.2 A). Interestingly, the decreased mobility of wt p66ShcA was not observed when MLK3 and kinase-dead JNK1 (JNK1KD) were co-expressed (Fig. 2 B). It was concluded from these results that the Shc kinase was not MLK3 or kinases downstream of MLK3 and upstream of JNK. These data suggested that JNK, when activated either by UV treatment or MLK3 expression, was able to phosphorylate p66ShcA in whole cells. Whole cell analysis indicated that the JNKs might be responsible for p66ShcA phosphorylation. An in vitro kinase assay was used to test candidate kinases directly. To generate recombinant wt p66ShcA and S36A p66ShcA proteins, wild type or mutant p66ShcAcDNAs were fused to the CBP sequence. Shc proteins were expressed as CBP fusion proteins and purified on a calmodulin affinity column. The recombinant Shc proteins were then used as substrates in a kinase assay to determine whether proteins in the MAPK pathway could phosphorylate Shc specifically at serine 36 in vitro. As shown in the Fig. 3, A and B, all kinases tested were capable of phosphorylating both themselves and MBP, indicating that all of the kinases tested were active in the kinase reactions. ERK1 (Fig. 3 B) and MEKK1 (data not shown) were not able to phosphorylate Shc proteins, whereas MLK1, MLK2, MLK3, MKK4, and MKK7 appeared to phosphorylate wt p66ShcA with no selectivity at serine 36 (Fig.3 C). In contrast, only ∼10% of radioactivity was incorporated into S36A p66ShcA relative to wt p66ShcA when JNK1 and JNK2 were incubated with Shc proteins (Fig. 3, B and C). Similarly, JNK3 and p38 also demonstrated some selectivity to the serine 36 site but to a lesser extent then JNK1 and JNK2. Furthermore, there was a decreased electrophoretic mobility of p66ShcA protein detected when JNKs and p38 were incubated with wt p66ShcA as compared with S36A p66ShcA (Fig. 3 B). The identities of the p66ShcA bands were confirmed by Western analysis (data not shown). These results demonstrated that JNK1, JNK2, JNK3, and p38, but not MLK1, MLK2, MLK3, MKK4, MKK7, ERK1 and MEKK1, were able to phosphorylate Shc at serine 36 selectively in vitro. The p46 and p52 Shc proteins are known to be tyrosine-phosphorylated and form a complex with Grb2 and SOS protein upon growth factor stimulation (12Pelicci G. Lanfrancone L. Grignani F. Forni G. Cavallo F. Forni G. Nicoletti I. Grinani F. Pawson T. Pelicci P.G. Cell. 1992; 70: 93-104Abstract Full Text PDF PubMed Scopus (1135) Google Scholar, 17Skolnik E.Y. Batzer A. Li N. Lee C.H. Lowenstein E. Mohammadi M. Margolis B. Schlessinger J. Science. 1993; 260: 1953-1955Crossref PubMed Scopus (502) Google Scholar, 18Egan S.E. Giddings B.W. Brooks M.W. Buday L. Sizeland A.M. Weinberg R.A. Nature. 1993; 363: 45-51Crossref PubMed Scopus (1008) Google Scholar, 19Aronheim A. Engelberg D. Li N. Al-Alawi N. Schlessinger J. Karin M. Cell. 1994; 78: 949-961Abstract Full Text PDF PubMed Scopus (422) Google Scholar, 20Kavanaugh W.M. Williams L.T. Science. 1994; 266: 1862-1865Crossref PubMed Scopus (450) Google Scholar, 21Ohmichi M. Matuoka K. Takenawa T. Saltiel A.R. J. Biol. Chem. 1994; 269: 1143-1148Abstract Full Text PDF PubMed Google Scholar). This complex formation couples receptors to the Ras pathway and is critical for cell proliferation and survival. Although p66ShcA is transiently phosphorylated at tyrosines upon growth factor stimulation, binding of Grb2 to p66ShcA does not lead to activation of Ras, but rather evidence suggests that p66ShcA may act as a sink for Grb2 and thereby effectively block growth factor-mediated responses (23Migliaccio E. Mele S. Salcini A.E. Pelicci G. Lai K.M. Superti-Furga G. Pawson T. Di Fiore P.P. Lanfrancone L. Pelicci P.G. EMBO J. 1997; 16: 706-716Crossref PubMed Scopus (362) Google Scholar, 30Okada S Kao A.W. Ceresa B.P. Blaikie P. Margolis B. Pessin J.E. J. Biol. Chem. 1997; 272: 28042-28049Abstract Full Text Full Text PDF PubMed Scopus (119) Google Scholar). To test whether serine phosphorylation of p66ShcA by UV irradiation altered its binding to Grb2, co-immunoprecipitation experiments were performed. As a control, SH-SY5Y cells were serum-starved and stimulated with insulin-like growth factor-1 (IGF-1) (24Kao A.W. Waters S.B. Okada S. Pessin J.E. Endocrinology. 1997; 138: 747-7480Crossref Scopus (51) Google Scholar). As expected, the amount of p66ShcA associated with Grb2, after normalizing to Grb2 protein in each anti-Grb2 immunoprecipitation, was 3.8-fold higher after IGF-1 stimulation (Fig.4, lanes 2 and 3). A greater association of Grb2 with p66ShcA was observed in the presence of serum as compared with serum-starved cells (Fig. 4,lanes 2 and 4). UV treatment in the presence of serum, however, resulted in a decreased amount of p66ShcAassociated with Grb2 (Fig. 4, lanes 4 and 5). Furthermore, we observed no mobility shift in the p66ShcAassociated with Grb2 either before or after UV treatment, suggesting that a non-serine phosphorylated form of p66ShcA may be associated with Grb2 (Fig. 4, lanes 4 and 5). Similar results were obtained when Shc proteins were immunoprecipitated and Western-blotted with Grb2 antibody (data not shown). These data support the conclusion that, unlike growth factor stimulation, serine-phosphorylated p66ShcA does not result in increased binding to Grb2 during UV irradiation. The p66ShcA protein appears to be a key protein in mediating cellular responses upon oxidative stress. P66ShcAknock-out mice are less susceptible to the pesticide paraquat and also live 30% longer than their normal counterparts (10Migliaccio E. Giorgio M. Mele S. Pelicci G. Reboldi P. Pandolfi P.P. Lanfrancone L. Pelicci P.G. Nature. 1999; 402: 309-313Crossref PubMed Scopus (1463) Google Scholar). Of particular interest is the demonstration that phosphorylation of p66ShcA at serine 36 is important for the normal cell death response due to oxidative damage. Blocking phosphorylation of serine 36 prevents hydrogen peroxide-induced cell death in fibroblasts (10Migliaccio E. Giorgio M. Mele S. Pelicci G. Reboldi P. Pandolfi P.P. Lanfrancone L. Pelicci P.G. Nature. 1999; 402: 309-313Crossref PubMed Scopus (1463) Google Scholar). In consideration of these observations, it was of interest to determine the kinase(s) that mediated serine 36 phosphorylation of p66ShcA in response to UV irradiation. In a UV-irradiated SH-SY5Y model, it is first shown that an inhibitor of the MLK pathway, CEP-1347, prevents p66ShcAphosphorylation (Fig. 1). This inhibition appears to be specific because p38, phosphatidylinositol 3-kinase, and MEK1 inhibitors have no effect. CEP-1347 has been previously demonstrated to inhibit members of the MLK family, which are upstream activators of MKK4/7 leading to JNK activation. Thus, our initial results implicated members of the MLK family or kinases downstream of these proteins as potential Shc kinases. Phosphorylation of p66ShcA at serine 36 is blocked in cells overexpressing MLK3 and a kinase-dead JNK1 (Fig. 2) suggesting that JNK1 is an Shc kinase. In support of these findings, three JNK isoforms can phosphorylate p66ShcA, predominantly at serine 36, as determined in an isolated kinase assay (Fig. 3). It is concluded from both the whole cell and in vitro analyses that we have identified JNKs as candidate Shc kinases mediating phosphorylation at serine 36 of p66ShcA. The JNKs (also called stress-activated protein kinases (SAPKs)) are an integral part of the signal transduction pathways that transmit extracellular signals of stress and injury to a variety of cellular responses including cell death (5Karin M. Ann. N. Y. Acad. Sci. 1998; 851: 139-146Crossref PubMed Scopus (289) Google Scholar, 6Davis R.J. Hughes H. Cell. 2000; 103: 239-252Abstract Full Text Full Text PDF PubMed Scopus (3609) Google Scholar, 7Miekle K. Herdegen T. Prog. Neurobiol. 2000; 61: 45-60Crossref PubMed Scopus (434) Google Scholar). JNK is activated upon DNA and oxidative damage due to UV irradiation, hypoxia, or apoptotic agents such as Taxol (35Hibi M. Lin A. Smeal T. Minden A. Karin M. Genes Dev. 1993; 7: 2135-2148Crossref PubMed Scopus (1708) Google Scholar, 36Garay M. Gaarde W. Monia B.P. Nero P. Cioffi C.L. Biochem. Pharmacol. 2000; 59: 1033-1043Crossref PubMed Scopus (35) Google Scholar, 37Lee L.F. Li G. Templeton D.J. Ting J.P. J. Biol. Chem. 1998; 273: 28253-28260Abstract Full Text Full Text PDF PubMed Scopus (196) Google Scholar). By both molecular and pharmacological approaches, it has been demonstrated that blocking JNK activation can prevent apoptosis after UV irradiation and oxidative stress (9Salh B.S. Martens J. Hundal R.S. Yoganathan N. Charest D. Mui A. Gomez-Munot A. Mol. Cell. Biol. Res. Commun. 2000; 4: 158-165Crossref PubMed Scopus (26) Google Scholar,38Tournier C. Hess P. Yang D.D. Xu J. Turner T.K. Nimnual A. Bar-Sagi D. Jones S.N. Flavell R.A. Davis R.J. Science. 2000; 288: 870-874Crossref PubMed Scopus (1537) Google Scholar, 39Maroney A.C. Finn J.P. Bozyczko-Coyne D. O'Kane T. Neff N.T. Tolkovsky A.M. Park D.S. Yan C.Y.I. Troy C.M. Greene L.A. J. Neurochem. 1999; 73: 1901-1912PubMed Google Scholar, 40Hreniuk D. Garay M. Gaarde W. Monia B.P. McKay R.A. Cioffi C.L. Mol. Pharmacol. 2001; 59: 867-874Crossref PubMed Scopus (113) Google Scholar). One substrate of JNKs is the transcription factor c-Jun. In primary embryonic superior cervical ganglia and hippocampal neurons, activation of c-Jun after trophic withdrawal or potassium depolarization can lead to neuronal death, whereas blocking c-Jun either by neutralizing antibody, antisense oligonucleotides, or expression of dominant-negative proteins prevents cell death (41Estus S. Zaks W.J. Freeman R.S. Gruda M. Bravo R. Johnson E.M. J. Cell Biol. 1994; 127: 1717-1727Crossref PubMed Scopus (786) Google Scholar, 42Schlingensiepen K.H. Wallnik F Kunst M. Schlingensiepen R. Herdengen T. Brysch W. Cell. Mol. Neurobiol. 1994; 14: 487-505Crossref PubMed Scopus (108) Google Scholar, 43Eilers A. Whitfield J. Babij C. Rubin L.L. Ham J. J. Neurosci. 1998; 18: 1713-1724Crossref PubMed Google Scholar, 44Ham J. Babij C. Whitfield J. Pfarr C.M. Lallemand D. Yaniv M. Rubin L.L. Neuron. 1995; 14: 927-939Abstract Full Text PDF PubMed Scopus (757) Google Scholar). In support of the cell culture results, the hippocampal neurons from either JNK3 knock-out or phospho-null c-Jun mice are protected from kainate-induced cell death (45Yang D.D. Kuan C.Y. Whitmarsh A.J. Rincón M. Zheng T.S. Davis R.J. Rakic P. Flavell R.A. Nature. 1997; 389: 865-870Crossref PubMed Scopus (1114) Google Scholar, 46Behrens A. Sibilia M. Wagner E.F. Nat. Genet. 1999; 21: 326-329Crossref PubMed Scopus (594) Google Scholar). Although it is clear that blocking c-Jun is sufficient to prevent certain types of cell death, the discovery that p66ShcA is also a substrate of the JNKs suggests that perhaps more than one pathway is triggered by activation of JNKs leading to cell death. Whether p66ShcA phosphorylation and c-Jun activation represent two unique or redundant events leading to cell death remains to be elucidated. It has been reported that half of p66ShcA protein is phosphorylated at serine/threonine residues and associates with Grb2 protein upon epidermal growth factor stimulation (30Okada S Kao A.W. Ceresa B.P. Blaikie P. Margolis B. Pessin J.E. J. Biol. Chem. 1997; 272: 28042-28049Abstract Full Text Full Text PDF PubMed Scopus (119) Google Scholar). The serine/threonine-phosphorylated form of p66 competes with the p52 and p46 Shc protein for the limited pool of Grb2 and thus dominantly inhibits epidermal growth factor receptor downstream signaling events. We tested whether phosphorylated p66ShcA protein acts as a sink for Grb2 binding and thus may dominantly interfere or attenuate the survival pathway. Rather than an increase in p66ShcA-associated Grb2 binding, UV irradiation resulted in a decreased amount of p66ShcA protein associated with Grb2. These results are consistent with the lack of Grb2 binding to Taxol-induced serine-phosphorylated p66ShcA (25Yang C.H. Horwitz S.B. Cancer Res. 2000; 60: 5171-5178PubMed Google Scholar). Although these studies do not distinguish the specific serine phosphorylated sites induced by the various stimuli, overall the results suggest that serine phosphorylation may lead to distinct downstream events dependent perhaps upon the site of phosphorylation and the upstream kinases involved. Both JNKs and p38 are activated by UV irradiation and are capable of phosphorylating p66ShcA in vitro (Fig. 3). However, only JNKs appear to phosphorylate p66ShcA in SH-SY5Y cells, because inhibition of JNKs by CEP-1347 prevented p66ShcA phosphorylation, whereas inhibition of p38 kinase by SB25038 had no effect after UV irradiation (Fig. 1). Nevertheless, it is possible that the choice of kinase employed to phosphorylate p66ShcA may depend upon the cellular context. The genetic data from the p66ShcA knock-out mice suggest that serine phosphorylation of this protein may have profound effects on the extent of oxidative damage either directly inflicted or incurred with aging (10Migliaccio E. Giorgio M. Mele S. Pelicci G. Reboldi P. Pandolfi P.P. Lanfrancone L. Pelicci P.G. Nature. 1999; 402: 309-313Crossref PubMed Scopus (1463) Google Scholar). Our data link the phosphorylation of p66ShcA to the JNKs, a family well established as involved in oxidative stress responses. It will be of further interest to determine the downstream effects of p66ShcAphosphorylation and the extent to which this protein contributes to JNK-mediated cell death. We thank Dr. Jeffrey Pessin for providing p66ShcA cDNA, Beverly Holskin for helpful guidance in developing the recombinant Shc proteins, and Drs. Anne Camoratto, Donna Bozyczko-Coyne, and Craig Dionne for helpful discussions." @default.
• W1520408486 created "2016-06-24" @default.
• W1520408486 creator A5002088038 @default.
• W1520408486 creator A5015443302 @default.
• W1520408486 creator A5051594897 @default.
• W1520408486 date "2001-12-01" @default.
• W1520408486 modified "2023-10-13" @default.
• W1520408486 title "c-Jun N-terminal Kinase Specifically Phosphorylates p66ShcA at Serine 36 in Response to Ultraviolet Irradiation" @default.
• W1520408486 cites W1491979926 @default.
• W1520408486 cites W1530284699 @default.
• W1520408486 cites W1545168616 @default.
• W1520408486 cites W1577145787 @default.
• W1520408486 cites W1592540674 @default.
• W1520408486 cites W1630763432 @default.
• W1520408486 cites W1788426598 @default.
• W1520408486 cites W1922083656 @default.
• W1520408486 cites W1945304257 @default.
• W1520408486 cites W1968015127 @default.
• W1520408486 cites W1969188373 @default.
• W1520408486 cites W1971475788 @default.
• W1520408486 cites W1972366604 @default.
• W1520408486 cites W1986758681 @default.
• W1520408486 cites W1991765224 @default.
• W1520408486 cites W1994874890 @default.
• W1520408486 cites W1997859241 @default.
• W1520408486 cites W1999639156 @default.
• W1520408486 cites W2000269495 @default.
• W1520408486 cites W2004192319 @default.
• W1520408486 cites W2017857028 @default.
• W1520408486 cites W2022159175 @default.
• W1520408486 cites W2022185380 @default.
• W1520408486 cites W2031999073 @default.
• W1520408486 cites W2051161717 @default.
• W1520408486 cites W2052799365 @default.
• W1520408486 cites W2058342631 @default.
• W1520408486 cites W2069785923 @default.
• W1520408486 cites W2075003503 @default.
• W1520408486 cites W2076485183 @default.
• W1520408486 cites W2077880395 @default.
• W1520408486 cites W2083663211 @default.
• W1520408486 cites W2086541753 @default.
• W1520408486 cites W2089889881 @default.
• W1520408486 cites W2094155854 @default.
• W1520408486 cites W2104234098 @default.
• W1520408486 cites W2108898424 @default.
• W1520408486 cites W2119807130 @default.
• W1520408486 cites W2132970977 @default.
• W1520408486 cites W2153385508 @default.
• W1520408486 cites W2165209574 @default.
• W1520408486 doi "https://doi.org/10.1074/jbc.m106612200" @default.
• W1520408486 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11602589" @default.
• W1520408486 hasPublicationYear "2001" @default.
• W1520408486 type Work @default.
• W1520408486 sameAs 1520408486 @default.
• W1520408486 citedByCount "93" @default.
• W1520408486 countsByYear W15204084862012 @default.
• W1520408486 countsByYear W15204084862013 @default.
• W1520408486 countsByYear W15204084862014 @default.
• W1520408486 countsByYear W15204084862015 @default.
• W1520408486 countsByYear W15204084862016 @default.
• W1520408486 countsByYear W15204084862017 @default.
• W1520408486 countsByYear W15204084862018 @default.
• W1520408486 countsByYear W15204084862019 @default.
• W1520408486 countsByYear W15204084862020 @default.
• W1520408486 countsByYear W15204084862021 @default.
• W1520408486 countsByYear W15204084862022 @default.
• W1520408486 crossrefType "journal-article" @default.
• W1520408486 hasAuthorship W1520408486A5002088038 @default.
• W1520408486 hasAuthorship W1520408486A5015443302 @default.
• W1520408486 hasAuthorship W1520408486A5051594897 @default.
• W1520408486 hasBestOaLocation W15204084861 @default.
• W1520408486 hasConcept C111337013 @default.
• W1520408486 hasConcept C11960822 @default.
• W1520408486 hasConcept C121332964 @default.
• W1520408486 hasConcept C153911025 @default.
• W1520408486 hasConcept C184235292 @default.
• W1520408486 hasConcept C185544564 @default.
• W1520408486 hasConcept C185592680 @default.
• W1520408486 hasConcept C192562407 @default.
• W1520408486 hasConcept C2776414213 @default.
• W1520408486 hasConcept C2776798109 @default.
• W1520408486 hasConcept C2779664074 @default.
• W1520408486 hasConcept C2987116853 @default.
• W1520408486 hasConcept C41008148 @default.
• W1520408486 hasConcept C49040817 @default.
• W1520408486 hasConcept C55493867 @default.
• W1520408486 hasConcept C75473681 @default.
• W1520408486 hasConcept C76155785 @default.
• W1520408486 hasConcept C86803240 @default.
• W1520408486 hasConcept C95444343 @default.
• W1520408486 hasConceptScore W1520408486C111337013 @default.
• W1520408486 hasConceptScore W1520408486C11960822 @default.
• W1520408486 hasConceptScore W1520408486C121332964 @default.
• W1520408486 hasConceptScore W1520408486C153911025 @default.
• W1520408486 hasConceptScore W1520408486C184235292 @default.
• W1520408486 hasConceptScore W1520408486C185544564 @default.
• W1520408486 hasConceptScore W1520408486C185592680 @default.
• W1520408486 hasConceptScore W1520408486C192562407 @default.

• next